Cargando…
Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target
OBJECTIVES: To investigate the association of anti-citrullinated protein antibodies (ACPA) with changes in systemic bone mineral density (BMD) in patients with early rheumatoid arthritis (RA) after two years of treat-to-target. METHODS: BMD was measured at the lumbar spine (LS) and femoral neck (FN)...
Autores principales: | Bugatti, Serena, Bogliolo, Laura, Manzo, Antonio, De Stefano, Ludovico, Delvino, Paolo, Motta, Francesca, Montecucco, Carlomaurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236980/ https://www.ncbi.nlm.nih.gov/pubmed/34194443 http://dx.doi.org/10.3389/fimmu.2021.701922 |
Ejemplares similares
-
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis
por: Bugatti, Serena, et al.
Publicado: (2016) -
The Genetic, Environmental, and Immunopathological Complexity of Autoantibody-Negative Rheumatoid Arthritis
por: De Stefano, Ludovico, et al.
Publicado: (2021) -
Personalized Therapeutic Strategies in the Management of Osteoporosis in Patients with Autoantibody-Positive Rheumatoid Arthritis
por: D’Onofrio, Bernardo, et al.
Publicado: (2022) -
The Clinical Value of Autoantibodies in Rheumatoid Arthritis
por: Bugatti, Serena, et al.
Publicado: (2018) -
Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritis
por: Bugatti, Serena, et al.
Publicado: (2021)